# Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter

> **NCT02002962** · PHASE2 · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 60 (estimated)

## Conditions studied

- Atrial Flutter

## Interventions

- **PROCEDURE:** radiofrequency ablation
- **DRUG:** Botulinum Toxin Type A injection

## Key facts

- **NCT ID:** NCT02002962
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2015-06
- **Final completion:** 2016-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002962, "Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02002962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*